melatonin has been researched along with ADDH in 51 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "To assess the efficacy and safety of novel pediatric-appropriate, prolonged-release melatonin minitablets (PedPRM) versus placebo for insomnia in children and adolescents with autism spectrum disorder (ASD), with or without attention-deficit/hyperactivity disorder (ADHD) comorbidity, and neurogenetic disorders (NGD)." | 9.24 | Efficacy and Safety of Pediatric Prolonged-Release Melatonin for Insomnia in Children With Autism Spectrum Disorder. ( Breddy, J; Findling, RL; Frydman-Marom, A; Gringras, P; Nir, T, 2017) |
| "Children with neurodevelopmental disorders are at risk of sleep problems, typically difficulty getting to sleep, sleep/wake rhythm disturbances and reduced duration of sleep (insomnia)." | 5.42 | Melatonin for sleep problems in children with neurodevelopmental disorders. ( , 2015) |
| "To assess the efficacy and safety of novel pediatric-appropriate, prolonged-release melatonin minitablets (PedPRM) versus placebo for insomnia in children and adolescents with autism spectrum disorder (ASD), with or without attention-deficit/hyperactivity disorder (ADHD) comorbidity, and neurogenetic disorders (NGD)." | 5.24 | Efficacy and Safety of Pediatric Prolonged-Release Melatonin for Insomnia in Children With Autism Spectrum Disorder. ( Breddy, J; Findling, RL; Frydman-Marom, A; Gringras, P; Nir, T, 2017) |
| " To determine (1) the serum baseline daily variations and nocturnal excretion of melatonin in ADHD subtypes and (2) the effect of chronic administration of methylphenidate, as well as the effects on symptomatology, 136 children with ADHD (Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision: DSM-IV-TR criteria) were divided into subgroups using the "Children's Depression Inventory" (CDI)." | 5.19 | Methylphenidate ameliorates depressive comorbidity in ADHD children without any modification on differences in serum melatonin concentration between ADHD subtypes. ( Cubero-Millán, I; Fernández-López, L; Luna-del-Castillo, JD; Machado-Casas, I; Martínez-Serrano, S; Molina-Carballo, A; Muñoz-Hoyos, A; Ruiz-López, A; Tortosa-Pinto, P; Uberos, J, 2014) |
| "The purpose of this manuscript is to review the evidence generated by clinical trials of pharmaceuticals in autism spectrum disorder (ASD), describe challenges in the conduct of such trials, and discuss future directions RECENT FINDINGS: Clinical trials in ASD have produced several compounds to adequately support the pharmacological treatment of associated symptom domains: attention deficit hyperactivity disorder (methylphenidate, atomoxetine, and alpha agonists), irritability/aggression (risperidone and aripiprazole), sleep (melatonin), and weight gain associated with atypical antipsychotic use (metformin)." | 4.98 | Clinical trials in autism spectrum disorder: evidence, challenges and future directions. ( Anagnostou, E, 2018) |
| " Recent meta-analysis suggests that optimal dosage and dosing time might be important to maximize the efficacy of melatonin." | 2.82 | Role of Melatonin in the Management of Sleep and Circadian Disorders in the Context of Psychiatric Illness. ( Kim, K; Linnaranta, O; Moon, E; Partonen, T, 2022) |
| "Sleep hygiene reduced initial insomnia to <60 minutes in 5 cases, with an overall effect size in the group as a whole of 0." | 2.72 | Sleep hygiene and melatonin treatment for children and adolescents with ADHD and initial insomnia. ( Bomben, MM; Freeman, RD; Rea, KJ; Wasdell, MB; Weiss, MD, 2006) |
| " Clonidine, melatonin, L-theanine, eszopiclone and guanfacine were well tolerated with mild to moderate adverse events; zolpidem was associated with neuropsychiatric adverse effects." | 2.55 | Safety, Tolerability and Efficacy of Drugs for Treating Behavioural Insomnia in Children with Attention-Deficit/Hyperactivity Disorder: A Systematic Review with Methodological Quality Assessment. ( Anand, S; Besag, FMC; Chan, EW; Cortese, S; Tong, H; Wong, ICK, 2017) |
| " However, there is a lack of pharmaceutical preparations of melatonin that give details about their use for children and that give evidence-based guidelines about the dosage and timing of intake." | 2.49 | [Disturbed sleep in children with ADHD: is there a place for melatonin as a treatment option?]. ( Gabriëls, L; Holvoet, E, 2013) |
| " Regulated melatonin products and larger, well-designed trials to establish optimal dosing regimens and long-term safety are needed." | 2.46 | Melatonin treatment for insomnia in pediatric patients with attention-deficit/hyperactivity disorder. ( Bendz, LM; Scates, AC, 2010) |
| "Higher incidences of sleep disorders such as restless legs syndrome, periodic limb movement disorder and sleep-disordered breathing have been reported in paediatric ADHD populations compared with control populations." | 2.46 | Sleep problems in the child with attention-deficit hyperactivity disorder: defining aetiology and appropriate treatments. ( Salpekar, J; Weiss, MD, 2010) |
| "Children with neurodevelopmental disorders are at risk of sleep problems, typically difficulty getting to sleep, sleep/wake rhythm disturbances and reduced duration of sleep (insomnia)." | 1.42 | Melatonin for sleep problems in children with neurodevelopmental disorders. ( , 2015) |
| "Melatonin was higher in children with predominantly hyperactive-impulsive/conduct disorder subtype." | 1.39 | Methylphenidate effects on blood serotonin and melatonin levels may help to synchronise biological rhythms in children with ADHD. ( Augustin-Morales, MD; Contreras-Chova, F; Cubero-Millán, I; Justicia-Martínez, F; Khaldy-Belkadi, H; Molina-Carballo, A; Muñoz-Hoyos, A; Naranjo-Gómez, A; Ruiz-Ramos, MJ; Uberos, J, 2013) |
| "Melatonin is a powerful antioxidant and a synchronizer of many physiological processes." | 1.37 | Genetic variations of the melatonin pathway in patients with attention-deficit and hyperactivity disorders. ( Anckarsäter, H; Botros, HG; Boudarene, L; Bourgeron, T; Chaste, P; Clement, N; Delorme, R; Durand, C; Fauchereau, F; Gillberg, C; Gillberg, IC; Guillaume, JL; Huguet, G; Jockers, R; Konyukh, M; Launay, JM; Leblond, C; Leboyer, M; Lemière, N; Melke, J; Nygren, G; Pagan, C; Rastam, M; Scheid, I; Serrano, E; Ståhlberg, O; Toro, R, 2011) |
| "Melatonin was recommended by more than one-third of respondents." | 1.36 | Use of pharmacotherapy for insomnia in child psychiatry practice: A national survey. ( Kirchner, HL; Mindell, JA; Owens, JA; Rosen, CL, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (1.96) | 18.2507 |
| 2000's | 9 (17.65) | 29.6817 |
| 2010's | 33 (64.71) | 24.3611 |
| 2020's | 8 (15.69) | 2.80 |
| Authors | Studies |
|---|---|
| Tedroff, K | 1 |
| von Euler, M | 1 |
| Dahlén, E | 1 |
| van Andel, E | 2 |
| Bijlenga, D | 4 |
| Vogel, SWN | 2 |
| Beekman, ATF | 2 |
| Kooij, JJS | 2 |
| Moon, E | 1 |
| Kim, K | 1 |
| Partonen, T | 2 |
| Linnaranta, O | 1 |
| Larsson, I | 1 |
| Aili, K | 1 |
| Lönn, M | 1 |
| Svedberg, P | 1 |
| Nygren, JM | 1 |
| Ivarsson, A | 1 |
| Johansson, P | 1 |
| Ouadih-Moran, M | 1 |
| Muñoz-Hoyos, A | 3 |
| D'Marco, L | 1 |
| Molina-Carballo, A | 3 |
| Seiquer, I | 1 |
| Checa-Ros, A | 1 |
| Kimland, EE | 1 |
| Bardage, C | 1 |
| Collin, J | 1 |
| Järleborg, A | 1 |
| Ljung, R | 1 |
| Iliadou, AN | 1 |
| Yang, LL | 1 |
| Stiernborg, M | 1 |
| Skott, E | 1 |
| Söderström, Å | 1 |
| Giacobini, M | 1 |
| Lavebratt, C | 1 |
| Anand, S | 1 |
| Tong, H | 1 |
| Besag, FMC | 1 |
| Chan, EW | 1 |
| Cortese, S | 1 |
| Wong, ICK | 1 |
| Gringras, P | 1 |
| Nir, T | 1 |
| Breddy, J | 1 |
| Frydman-Marom, A | 1 |
| Findling, RL | 1 |
| Howes, OD | 1 |
| Rogdaki, M | 1 |
| Findon, JL | 1 |
| Wichers, RH | 1 |
| Charman, T | 1 |
| King, BH | 1 |
| Loth, E | 1 |
| McAlonan, GM | 1 |
| McCracken, JT | 1 |
| Parr, JR | 1 |
| Povey, C | 1 |
| Santosh, P | 1 |
| Wallace, S | 1 |
| Simonoff, E | 1 |
| Murphy, DG | 1 |
| Anagnostou, E | 1 |
| Park, G | 1 |
| Jung, YS | 1 |
| Park, MK | 1 |
| Yang, CH | 1 |
| Kim, YU | 1 |
| McDaid, C | 1 |
| Parker, A | 1 |
| Scantlebury, A | 1 |
| Fairhurst, C | 1 |
| Dawson, V | 1 |
| Elphick, H | 1 |
| Hewitt, C | 1 |
| Spiers, G | 1 |
| Thomas, M | 1 |
| Beresford, B | 1 |
| Snitselaar, MA | 1 |
| Smits, MG | 4 |
| van der Heijden, KB | 4 |
| Spijker, J | 1 |
| Holvoet, E | 1 |
| Gabriëls, L | 1 |
| Van Someren, EJ | 4 |
| Gruber, R | 1 |
| Bron, TI | 1 |
| Kruithof, IF | 1 |
| Spanbroek, EC | 1 |
| Kooij, JJ | 3 |
| Dijk, DJ | 1 |
| Efron, D | 1 |
| Lycett, K | 1 |
| Sciberras, E | 1 |
| Bloch, MH | 1 |
| Mulqueen, J | 1 |
| Cubero-Millán, I | 2 |
| Machado-Casas, I | 1 |
| Fernández-López, L | 1 |
| Martínez-Serrano, S | 1 |
| Tortosa-Pinto, P | 1 |
| Ruiz-López, A | 1 |
| Luna-del-Castillo, JD | 1 |
| Uberos, J | 2 |
| Furster, C | 1 |
| Hallerbäck, MU | 1 |
| Bock, DE | 1 |
| Roach-Fox, E | 1 |
| Seabrook, JA | 1 |
| Rieder, MJ | 1 |
| Matsui, D | 1 |
| Büber, A | 1 |
| Çakaloz, B | 1 |
| Işıldar, Y | 1 |
| Ünlü, G | 1 |
| Bostancı, HE | 1 |
| Aybek, H | 1 |
| Herken, H | 1 |
| Puustjärvi, A | 1 |
| Raunio, H | 1 |
| Lecklin, A | 1 |
| Kumpulainen, K | 1 |
| Punja, S | 1 |
| Nikles, CJ | 1 |
| Senior, H | 1 |
| Mitchell, G | 1 |
| Schmid, CH | 1 |
| Heussler, H | 1 |
| Witmans, M | 1 |
| Vohra, S | 1 |
| Coogan, AN | 2 |
| McGowan, NM | 1 |
| Hellmer, K | 1 |
| Nyström, P | 1 |
| Lahti, TA | 1 |
| Snowden, S | 1 |
| Hoebert, M | 1 |
| van Geijlswijk, IM | 1 |
| Bendz, LM | 1 |
| Scates, AC | 1 |
| Van Veen, MM | 1 |
| Boonstra, AM | 1 |
| Gordijn, MC | 1 |
| Geoffroy, MB | 1 |
| Owens, JA | 1 |
| Rosen, CL | 1 |
| Mindell, JA | 1 |
| Kirchner, HL | 1 |
| Weiss, MD | 2 |
| Salpekar, J | 1 |
| Rizzi, DA | 1 |
| Chaste, P | 1 |
| Clement, N | 1 |
| Botros, HG | 1 |
| Guillaume, JL | 1 |
| Konyukh, M | 1 |
| Pagan, C | 1 |
| Scheid, I | 1 |
| Nygren, G | 1 |
| Anckarsäter, H | 1 |
| Rastam, M | 1 |
| Ståhlberg, O | 1 |
| Gillberg, IC | 1 |
| Melke, J | 1 |
| Delorme, R | 1 |
| Leblond, C | 1 |
| Toro, R | 1 |
| Huguet, G | 1 |
| Fauchereau, F | 1 |
| Durand, C | 1 |
| Boudarene, L | 1 |
| Serrano, E | 1 |
| Lemière, N | 1 |
| Launay, JM | 1 |
| Leboyer, M | 1 |
| Jockers, R | 1 |
| Gillberg, C | 1 |
| Bourgeron, T | 1 |
| Nováková, M | 1 |
| Paclt, I | 2 |
| Ptáček, R | 2 |
| Kuželová, H | 2 |
| Hájek, I | 1 |
| Sumová, A | 1 |
| Baird, AL | 1 |
| Siddiqui, A | 1 |
| Donev, RM | 1 |
| Thome, J | 1 |
| Cermáková, N | 1 |
| Trefilová, A | 1 |
| Kollárová, P | 1 |
| Cálková, T | 1 |
| Csemy, L | 1 |
| Cíhal, L | 1 |
| Naranjo-Gómez, A | 1 |
| Justicia-Martínez, F | 1 |
| Ruiz-Ramos, MJ | 1 |
| Contreras-Chova, F | 1 |
| Augustin-Morales, MD | 1 |
| Khaldy-Belkadi, H | 1 |
| Tjon Pian Gi, CV | 1 |
| Broeren, JPA | 1 |
| Starreveld, JS | 1 |
| A Versteegh, FG | 1 |
| Gunning, WB | 2 |
| Wasdell, MB | 1 |
| Bomben, MM | 1 |
| Rea, KJ | 1 |
| Freeman, RD | 1 |
| Szeinberg, A | 1 |
| Borodkin, K | 1 |
| Dagan, Y | 1 |
| Ridderinkhof, KR | 1 |
| Barton, R | 1 |
| Sandyk, R | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| An Observational Study Investigating the Experience of Patients Undergoing Active Insomnia Clinical Trials[NCT05978271] | 500 participants (Anticipated) | Observational | 2024-08-31 | Not yet recruiting | |||
| A Randomized, Placebo-controlled Study to Investigate the Efficacy and Safety of Circadin® to Alleviate Sleep Disturbances in Children With Neurodevelopmental Disabilities[NCT01906866] | Phase 3 | 125 participants (Actual) | Interventional | 2013-10-31 | Completed | ||
| Melatonin in Youth: N-of-1 Trials in a Stimulant-treated Attention Deficit Hyperactivity Disorder (ADHD) Population[NCT02333149] | Phase 3 | 0 participants (Actual) | Interventional | 2019-01-01 | Withdrawn (stopped due to Issues surrounding the current COVID-19 pandemic.) | ||
| Characterization of Endogenous Melatonin Profiles in Children With Autism Spectrum Disorder.[NCT00691080] | 58 participants (Actual) | Observational | 2007-09-30 | Completed | |||
| The Therapeutic Effect of Melatonin in Pediatric Patients With Functional Dyspepsia[NCT04684199] | 14 participants (Actual) | Interventional | 2014-08-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
questionnaire - To compare the treatment effect of Circadin® 2/5 mg minitablets to that of placebo on sleep latency as derived from a Sleep and Nap Diary after 13 weeks of double-blind treatment (NCT01906866)
Timeframe: 13 weeks
| Intervention | minutes (Mean) |
|---|---|
| Circadin 2/5/10 mg | -37.77 |
| Placebo | -12.57 |
Total Sleep Time - To compare the treatment effect of Circadin® 2/5 mg minitablets to that of placebo on total sleep time (TST) as assessed by the Sleep and Nap Diary after 13 weeks of double-blind treatment (NCT01906866)
Timeframe: 13 weeks
| Intervention | minutes (Mean) |
|---|---|
| Circadin 2/5/10 mg | 51.03 |
| Placebo | 18.71 |
16 reviews available for melatonin and ADDH
| Article | Year |
|---|---|
Role of Melatonin in the Management of Sleep and Circadian Disorders in the Context of Psychiatric Illness.
Topics: Attention Deficit Disorder with Hyperactivity; Bipolar Disorder; Circadian Rhythm; Humans; Melatonin | 2022 |
Sleep interventions for children with attention deficit hyperactivity disorder (ADHD): A systematic literature review.
Topics: Attention Deficit Disorder with Hyperactivity; Behavior Therapy; Child; Humans; Melatonin; Quality o | 2023 |
Safety, Tolerability and Efficacy of Drugs for Treating Behavioural Insomnia in Children with Attention-Deficit/Hyperactivity Disorder: A Systematic Review with Methodological Quality Assessment.
Topics: Attention Deficit Disorder with Hyperactivity; Child; Clonidine; Eszopiclone; Glutamates; Guanfacine | 2017 |
Autism spectrum disorder: Consensus guidelines on assessment, treatment and research from the British Association for Psychopharmacology.
Topics: Animals; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Autism Spectrum D | 2018 |
Clinical trials in autism spectrum disorder: evidence, challenges and future directions.
Topics: Adrenergic alpha-Agonists; Adrenergic Uptake Inhibitors; Aggression; Antipsychotic Agents; Aripipraz | 2018 |
Outcome domains and outcome measures used in studies assessing the effectiveness of interventions to manage non-respiratory sleep disturbances in children with neurodisabilities: a systematic review.
Topics: Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Central Nervous System Depr | 2019 |
Sleep and Circadian Rhythmicity in Adult ADHD and the Effect of Stimulants.
Topics: Adult; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Circadian R | 2017 |
[Disturbed sleep in children with ADHD: is there a place for melatonin as a treatment option?].
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Central Nervous System Depressants; Child | 2013 |
The circadian rhythm in adult attention-deficit/hyperactivity disorder: current state of affairs.
Topics: Adult; Attention; Attention Deficit Disorder with Hyperactivity; Circadian Rhythm; Humans; Melatonin | 2013 |
Nutritional supplements for the treatment of ADHD.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Child; Child, Preschool; Dietary Suppleme | 2014 |
[Drug therapy and the most common drugs for childhood psychiatric disorders].
Topics: Antidepressive Agents; Attention Deficit Disorder with Hyperactivity; Child; Humans; Melatonin; Ment | 2016 |
A systematic review of circadian function, chronotype and chronotherapy in attention deficit hyperactivity disorder.
Topics: Attention Deficit Disorder with Hyperactivity; Chronotherapy; Circadian Clocks; Humans; Melatonin; S | 2017 |
Question 1. Does melatonin improve sleep pattern in children with attention deficit hyperactivity disorder?
Topics: Attention Deficit Disorder with Hyperactivity; Central Nervous System Depressants; Child; Evidence-B | 2009 |
Melatonin treatment for insomnia in pediatric patients with attention-deficit/hyperactivity disorder.
Topics: Attention Deficit Disorder with Hyperactivity; Child; Humans; Melatonin; Sleep Initiation and Mainte | 2010 |
Sleep problems in the child with attention-deficit hyperactivity disorder: defining aetiology and appropriate treatments.
Topics: Adrenergic alpha-Agonists; Antidepressive Agents; Attention Deficit Disorder with Hyperactivity; Beh | 2010 |
Use of medication in children with psychiatric disorders.
Topics: Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Child Psychiatry; D | 2007 |
10 trials available for melatonin and ADDH
| Article | Year |
|---|---|
Attention-Deficit/Hyperactivity Disorder and Delayed Sleep Phase Syndrome in Adults: A Randomized Clinical Trial on the Effects of Chronotherapy on Sleep.
Topics: Adult; Attention Deficit Disorder with Hyperactivity; Chronotherapy; Circadian Rhythm; Humans; Melat | 2022 |
Is S100B Involved in Attention-Deficit/Hyperactivity Disorder (ADHD)? Comparisons with Controls and Changes Following a Triple Therapy Containing Methylphenidate, Melatonin and ω-3 PUFAs.
Topics: Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Fatty Acids | 2023 |
Effects of chronotherapy on circadian rhythm and ADHD symptoms in adults with attention-deficit/hyperactivity disorder and delayed sleep phase syndrome: a randomized clinical trial.
Topics: Adult; Attention Deficit Disorder with Hyperactivity; Chronotherapy; Circadian Rhythm; Humans; Light | 2021 |
Efficacy and Safety of Pediatric Prolonged-Release Melatonin for Insomnia in Children With Autism Spectrum Disorder.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Central Nervous | 2017 |
Use of sleep medication in children with ADHD.
Topics: Adolescent; Anxiety Disorders; Attention Deficit and Disruptive Behavior Disorders; Attention Defici | 2014 |
Methylphenidate ameliorates depressive comorbidity in ADHD children without any modification on differences in serum melatonin concentration between ADHD subtypes.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; | 2014 |
Melatonin in Youth: N-of-1 trials in a stimulant-treated ADHD Population (MYNAP): study protocol for a randomized controlled trial.
Topics: Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Clinical Protocols | 2016 |
Melatonin for treatment of sleeping disorders in children with attention deficit/hyperactivity disorder: a preliminary open label study.
Topics: Attention Deficit Disorder with Hyperactivity; Central Nervous System Depressants; Central Nervous S | 2003 |
Sleep hygiene and melatonin treatment for children and adolescents with ADHD and initial insomnia.
Topics: Adolescent; Arousal; Attention Deficit Disorder with Hyperactivity; Child; Circadian Rhythm; Cross-O | 2006 |
Sleep hygiene and melatonin treatment for children and adolescents with ADHD and initial insomnia.
Topics: Adolescent; Arousal; Attention Deficit Disorder with Hyperactivity; Child; Circadian Rhythm; Cross-O | 2006 |
Sleep hygiene and melatonin treatment for children and adolescents with ADHD and initial insomnia.
Topics: Adolescent; Arousal; Attention Deficit Disorder with Hyperactivity; Child; Circadian Rhythm; Cross-O | 2006 |
Sleep hygiene and melatonin treatment for children and adolescents with ADHD and initial insomnia.
Topics: Adolescent; Arousal; Attention Deficit Disorder with Hyperactivity; Child; Circadian Rhythm; Cross-O | 2006 |
Effect of melatonin on sleep, behavior, and cognition in ADHD and chronic sleep-onset insomnia.
Topics: Attention Deficit Disorder with Hyperactivity; Child; Child Behavior Disorders; Chronic Disease; Cir | 2007 |
25 other studies available for melatonin and ADDH
| Article | Year |
|---|---|
Melatonin usage in children and young adults, a registry-based cohort study.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Child; Cohort S | 2022 |
Pediatric use of prescribed melatonin in Sweden 2006-2017: a register based study.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Child; Female; Humans; Male; Melatonin; P | 2021 |
Proinflammatory mediators and their associations with medication and comorbid traits in children and adults with ADHD.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Attention Deficit Disorder with Hyperactivity; Autistic Di | 2020 |
Melatonin inhibits attention-deficit/hyperactivity disorder caused by atopic dermatitis-induced psychological stress in an NC/Nga atopic-like mouse model.
Topics: Animals; Attention Deficit Disorder with Hyperactivity; Brain; Cell Line, Transformed; Dermatitis, A | 2018 |
Body temperature, activity and melatonin profiles in adults with attention-deficit/hyperactivity disorder and delayed sleep: a case-control study.
Topics: Adult; Attention Deficit Disorder with Hyperactivity; Body Temperature; Case-Control Studies; Circad | 2013 |
Why do we sleep so late?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Attention Deficit Disorder with Hyperactivity; Circadian | 2013 |
The use of melatonin in Swedish children and adolescents--a register-based study according to age, gender, and medication of ADHD.
Topics: Adolescent; Adolescent Behavior; Age Factors; Attention Deficit Disorder with Hyperactivity; Central | 2015 |
Melatonin for sleep problems in children with neurodevelopmental disorders.
Topics: Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Child; Humans; Hypnotics an | 2015 |
Sleep-promoting medications in children: physician prescribing habits in Southwestern Ontario, Canada.
Topics: Antidepressive Agents; Attention Deficit Disorder with Hyperactivity; Benzodiazepines; Cross-Section | 2016 |
Increased urinary 6-hydroxymelatoninsulfate levels in attention deficit hyperactivity disorder diagnosed children and adolescent.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Case-Control Studies; Child; Circadian Rh | 2016 |
Infant acetylcholine, dopamine, and melatonin dysregulation: Neonatal biomarkers and causal factors for ASD and ADHD phenotypes.
Topics: Acetylcholine; Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Biomarkers; | 2017 |
CREM mutations and ADHD symptoms.
Topics: Animals; Attention Deficit Disorder with Hyperactivity; Cyclic AMP Response Element Modulator; Human | 2009 |
Long-term follow-up of melatonin treatment in children with ADHD and chronic sleep onset insomnia.
Topics: Affect; Attention Deficit Disorder with Hyperactivity; Central Nervous System Depressants; Chi-Squar | 2009 |
Delayed circadian rhythm in adults with attention-deficit/hyperactivity disorder and chronic sleep-onset insomnia.
Topics: Actigraphy; Adolescent; Adult; Attention Deficit Disorder with Hyperactivity; Chi-Square Distributio | 2010 |
[Fighting with the Danish Medical Agency--core activity of the medical profession?].
Topics: Attention Deficit Disorder with Hyperactivity; Central Nervous System Depressants; Humans; Melatonin | 2010 |
Use of pharmacotherapy for insomnia in child psychiatry practice: A national survey.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Attitude of Health Personnel; Child; Chil | 2010 |
[Fighting with the Danish Medical Agency--core activity of the medical profession?].
Topics: Attention Deficit Disorder with Hyperactivity; Central Nervous System Depressants; Denmark; Humans; | 2010 |
Genetic variations of the melatonin pathway in patients with attention-deficit and hyperactivity disorders.
Topics: Acetylserotonin O-Methyltransferase; Arylalkylamine N-Acetyltransferase; Attention Deficit Disorder | 2011 |
Salivary melatonin rhythm as a marker of the circadian system in healthy children and those with attention-deficit/hyperactivity disorder.
Topics: Attention Deficit Disorder with Hyperactivity; Biomarkers; Child; Circadian Rhythm; Czech Republic; | 2011 |
Adult attention-deficit hyperactivity disorder is associated with alterations in circadian rhythms at the behavioural, endocrine and molecular levels.
Topics: Actigraphy; Adult; ARNTL Transcription Factors; Attention Deficit Disorder with Hyperactivity; Case- | 2012 |
Circadian rhythms of saliva melatonin in ADHD, anxious and normal children.
Topics: Anxiety Disorders; Attention Deficit Disorder with Hyperactivity; Child; Circadian Rhythm; Humans; M | 2011 |
Methylphenidate effects on blood serotonin and melatonin levels may help to synchronise biological rhythms in children with ADHD.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Body Height; Body Mass Index; Body Weight | 2013 |
Idiopathic chronic sleep onset insomnia in attention-deficit/hyperactivity disorder: a circadian rhythm sleep disorder.
Topics: Attention Deficit Disorder with Hyperactivity; Child; Data Interpretation, Statistical; Environmenta | 2005 |
Melatonin treatment in adolescents with delayed sleep phase syndrome.
Topics: Administration, Oral; Adolescent; Age Factors; Analysis of Variance; Attention Deficit Disorder with | 2006 |
Zinc deficiency in attention-deficit hyperactivity disorder.
Topics: Attention Deficit Disorder with Hyperactivity; Child, Preschool; Humans; Infant; Melatonin; Zinc | 1990 |